Search

Medtronic PLC

Slēgts

SektorsVeselības aprūpe

91.22 0.78

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

90.18

Max

91.97

Galvenie mērījumi

By Trading Economics

Ienākumi

130M

1.3B

Pārdošana

789M

9.8B

P/E

Sektora vidējais

23.345

57.002

EPS

1.55

Dividenžu ienesīgums

3.26

Peļņas marža

12.981

Darbinieki

95,000

EBITDA

147M

2.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+5.46% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

3.26%

2.22%

Nākamie ieņēmumi

2026. g. 1. sept.

Nākamais dividenžu datums

2026. g. 16. okt.

Nākamais Ex dividenžu datums

2026. g. 25. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

14B

109B

Iepriekšējā atvēršanas cena

90.44

Iepriekšējā slēgšanas cena

91.22

Ziņu noskaņojums

By Acuity

20%

80%

58 / 340 Rangs Healthcare

Medtronic PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. aug. 21:51 UTC

Medtronic PLC shares are lower in after-market hours, with no specific news cited. Broader market declines follow a report of falling U.S. retail sales.

2026. g. 13. aug. 23:01 UTC

Medtronic PLC shares are lower in after-market hours, continuing a decline from earlier losses amid mixed signals on labor market strength and inflation.

2026. g. 12. aug. 23:01 UTC

Medtronic PLC shares are lower in after-market trading, reflecting a retracement from an earlier peak while remaining above the 20-day moving average.

2026. g. 11. aug. 23:01 UTC

Shares of Medtronic PLC were lower during after-market hours, despite a brief uptick earlier in the session. No specific news was identified.

2026. g. 10. aug. 23:21 UTC

Medtronic PLC shares are higher in after-market trading, continuing an upward trend since Monday's close and remaining above the 20-day moving average.

2026. g. 8. aug. 00:02 UTC

Medtronic PLC shares are lower in after-market hours amid a volatile session. A weak jobs report has influenced broader market expectations for interest rate hikes.

2026. g. 7. aug. 23:26 UTC

Medtronic PLC shares are higher in after-market hours, supported by overall market strength and strong performances from major tech stocks.

2026. g. 6. aug. 20:06 UTC

News

Medtronic PLC announced expanded CE Mark approval for its Sphere-9 Catheter, yet shares are trading lower since Wednesday's close after an earlier uptick.

2026. g. 5. aug. 19:52 UTC

News

Medtronic PLC shares are lower today amid increased put options volume, reflecting bearish sentiment ahead of the upcoming earnings report on September 1st.

2026. g. 4. aug. 20:06 UTC

News

Medtronic PLC shares are lower after a jury ruled the company owes $88 million for damages related to Covidien's hernia mesh products.

2026. g. 3. aug. 23:02 UTC

Medtronic PLC shares are lower in after-market hours, reflecting selling pressure despite trading above its 20-day moving average. No specific news was identified.

2026. g. 31. jūl. 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, following unusual trading activity and amid rising U.S. Treasury yields and crude oil prices.

2026. g. 30. jūl. 23:31 UTC

Medtronic PLC shares are modestly higher in after-market trading, remaining near the upper end of their one-month range. No specific news was identified.

2026. g. 29. jūl. 21:51 UTC

Medtronic PLC shares are lower in after-market hours, reflecting broader market declines amid renewed inflation and interest rate concerns linked to rising crude oil prices.

2026. g. 28. jūl. 23:26 UTC

Shares of Medtronic PLC are trading higher in after-market hours, maintaining above the 20-day moving average amid a trend of five consecutive daily gains.

2026. g. 27. jūl. 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, continuing an upward trend and supported by positive sentiment in European markets.

2026. g. 24. jūl. 23:26 UTC

Medtronic PLC's after-market trading remains roughly flat, showing routine performance within a narrow range since Friday's close.

2026. g. 23. jūl. 23:02 UTC

Medtronic PLC shares are trading higher in after-market hours, reaching near the top of their one-month trading range amid broader market stability.

2026. g. 22. jūl. 19:36 UTC

News

Medtronic PLC shares are lower as competition increases from Johnson & Johnson's newly authorized Ottava Surgical Robot for U.S. robotic soft-tissue surgery.

2026. g. 21. jūl. 20:07 UTC

News

Medtronic PLC shares are lower today, impacted by declines in the Health Care Equipment sector. The company recently launched its AI-native surgical platform, Touch Surgery™ Aide.

2026. g. 20. jūl. 22:31 UTC

Medtronic PLC shares are higher in after-market hours, reflecting positive movement in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

Salīdzinājums

Cenas izmaiņa

Medtronic PLC Prognoze

Cenas mērķis

By TipRanks

5.46% augšup

Prognoze 12 mēnešiem

Vidējais 95.53 USD  5.46%

Augstākais 118 USD

Zemākais 80 USD

Pamatojoties uz 19 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Medtronic PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

19 ratings

13

Pirkt

6

Turēt

0

Pārdot

Noskaņojums

By Acuity

58 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat